SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
11.49
-0.04 (-0.35%)
At close: Sep 18, 2026, 4:00 PM EDT
11.55
+0.06 (0.52%)
Pre-market: Sep 21, 2026, 4:13 AM EDT
SLS Market Cap
SLS has a market cap or net worth of $2.32 billion as of September 18, 2026. Its market cap has increased by 1,203.57% in one year.
Market Cap
2.32B
Enterprise Value
2.18B
1-Year Change
1,203.57%
Ranking
Category
Stock Price
$11.49
ChartMarket Cap Chart
Since March 12, 2008, SLS's market cap has increased from $133.40M to $2.32B, an increase of 1,639.40%. That is a compound annual growth rate of 16.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.32B | 332.10% |
| Dec 31, 2025 | 537.00M | 633.61% |
| Dec 31, 2024 | 73.20M | 115.29% |
| Dec 29, 2023 | 34.00M | -30.04% |
| Dec 30, 2022 | 48.60M | -44.65% |
| Dec 31, 2021 | 87.80M | 59.64% |
| Dec 31, 2020 | 55.00M | 163.16% |
| Dec 31, 2019 | 20.90M | -22.88% |
| Dec 31, 2018 | 27.10M | 125.83% |
| Dec 29, 2017 | 12.00M | -43.13% |
| Dec 30, 2016 | 21.10M | -91.13% |
| Dec 31, 2015 | 238.00M | 29.77% |
| Dec 31, 2014 | 183.40M | -64.87% |
| Dec 31, 2013 | 522.00M | 404.35% |
| Dec 31, 2012 | 103.50M | 412.38% |
| Dec 30, 2011 | 20.20M | -57.38% |
| Dec 31, 2010 | 47.40M | -36.12% |
| Dec 31, 2009 | 74.20M | -6.31% |
| Dec 31, 2008 | 79.20M | -40.63% |
| Mar 12, 2008 | 133.40M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Structure Therapeutics | 2.50B |
| Beam Therapeutics | 2.49B |
| Viridian Therapeutics | 2.49B |
| Mineralys Therapeutics | 2.48B |
| Vera Therapeutics | 2.45B |
| Harmony Biosciences Holdings | 2.45B |
| Nektar Therapeutics | 2.29B |
| Aurinia Pharmaceuticals | 2.25B |